45 CFR § 180 compliance
D · 65
This hospital published part of what § 180 requires.
●Machine-readable file published: assessment threshold met
●Gross / standard charges: assessment threshold met
●Discounted cash price: assessment threshold met
○Payer-specific negotiated rates: below assessment threshold
○Min / max negotiated charges: below assessment threshold
●Free, public, no login required: assessment threshold met
Procedures listed
4,762
Insurances with rates
0
CPT / HCPCS codes
0
Most expensive procedures (gross)
00441022
$125,145
vutrisiran 25 mg/0.5 mL Injection
Gross
$208,575
00433276
$75,816
tremelimumab actl 20 mg/mL Sol
Gross
$126,360
00406231
$66,349
ipilimumab 5 mg/mL IV Soln 40 mL
Gross
$110,582
00405290
$45,648
ravulizumab-cwvz 100 mg/mL intravenous solution 11 mL
Gross
$76,080
00405696
$43,226
inotuzumab ozogamicin 0.9 mg intravenous injection
Gross
$72,043
00440925
$41,555
mitoMYcin 80 mg Kit
Gross
$69,259
00405399
$34,104
polatuzumab vedotin-piiq 140 mg intravenous injection
Gross
$56,840
00405324
$31,914
tildrakizumab-asmn 100 mg/mL subcutaneous solution 1 mL
Gross
$53,190
00405274
$30,949
teprotumumab-trbw 500 mg intravenous injection
Gross
$51,582
00439117
$28,252
nivolumab-relatlimab rmbw 240 mg-80 mg/20 mL Sol
Gross
$47,086
00406272
$27,216
pegloticase 8 mg/mL IV Soln 1 mL
Gross
$45,360
00405605
$27,064
ustekinumab 45 mg/0.5 mL Subcut Soln 0.5 mL
Gross
$45,106
00406397
$26,962
cabazitaxel 60 mg/1.5 mL IV Soln 1.5 mL
Gross
$44,937
00433383
$22,038
dostarlimab gxly 500 mg/10 mL Sol
Gross
$36,730
00406025
$21,971
brentuximab vedotin 50 mg IV Inj
Gross
$36,619
00405944
$20,618
atezolizumab 60 mg/mL IV Soln 20 mL
Gross
$34,363
00433649
$20,359
ublituximab xiiy 150 mg/6 mL Sol
Gross
$33,931
00433516
$19,866
glofitamab gxbm 1 mg/mL Sol 10 mL
Gross
$33,110
00405597
$19,436
cemiplimab-rwlc 350 mg/7 mL intravenous solution 7 mL
Gross
$32,394
00404962
$19,063
risankizumab rzaa 60 mg/mL Sol 10 mL
Gross
$31,772
00405340
$18,844
daratumumab-hyaluronidase-fihj 1800 mg-30,000 units/15 mL subcutaneous solution 15 mL
Gross
$31,406
00406124
$16,848
vedolizumab 300 mg IV Inj
Gross
$28,080
00406249
$16,588
ipilimumab 5 mg/mL IV Soln 10 mL
Gross
$27,646
00418418
$16,130
tenecteplase 50 mg IV Inj
Gross
$26,884
00406173
$16,023
obinutuzumab 25 mg/mL IV Soln 40 mL
Gross
$26,705
00406199
$15,959
natalizumab 300 mg/15 mL
Gross
$26,599
00405472
$14,852
lurbinectedin 4 mg intravenous injection
Gross
$24,754
00405738
$14,551
nivolumab 10 mg/mL IV Soln 24 mL
Gross
$24,252
00413955
$14,492
agalsidase beta 35 mg IV Inj
Gross
$24,154
00405449
$14,433
atezolizumab 840 mg/14 mL intravenous solution 14 mL
Gross
$24,055
00425090
$14,113
antivenin (Micrurus fulvius) IV kit
Gross
$23,522
00421248
$14,059
hemin 313 mg IV Inj
Gross
$23,431
00418020
$13,951
carmustine 7.7 mg Implant Devive
Gross
$23,252
00406157
$13,883
ramucirumab 10 mg/mL IV Soln 50 mL
Gross
$23,138
00412882
$13,679
immune globulin 10% IV Soln 400 mL (Privigen)
Gross
$22,799
00406041
$12,814
panitumumab 20 mg/mL IV Soln 20 mL
Gross
$21,357
00406223
$12,688
pertuzumab 420 mg/14 mL IV Soln 14 mL
Gross
$21,147
00406462
$12,681
eculizumab 10 mg/mL IV Soln 30 mL
Gross
$21,135
00406132
$12,477
pegfilgrastim 6 mg/0.6 mL Sol (Onpro Kit)
Gross
$20,795
00406942
$12,477
pegfilgrastim 6 mg/0.6 mL Subcut Soln 0.6 mL (Syringe)
Gross
$20,795
00405563
$12,454
ravulizumab-cwvz 10 mg/mL intravenous solution 30 mL
Gross
$20,756
00433714
$12,449
ravulizumab-cwvz 100 mg/mL Sol 3mL
Gross
$20,749
00406405
$12,134
PRALAtrexate 20 mg/mL IV Soln 1 mL
Gross
$20,223
00405415
$12,105
ado-trastuzumab emtansine 160 mg IV Inj
Gross
$20,175
00404954
$11,798
efgartigimod alfa 400 mg/20 mL Sol
Gross
$19,664
00406439
$11,293
ixabepilone 45 mg intravenous injection
Gross
$18,822
00405639
$11,036
benralizumab 30 mg/mL subcutaneous solution 1 mL
Gross
$18,393
00406017
$10,804
pembrolizumab 25 mg/mL IV Soln 4 mL
Gross
$18,007
00405746
$10,315
siltuximab 400 mg intravenous injection
Gross
$17,192
00405662
$10,004
leuprolide 11.25 mg/3 months IM Inj, ER
Gross
$16,674
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 00441022 | vutrisiran 25 mg/0.5 mL Injection | $208,575 | $125,145 | — | — | 0 |
| 00433276 | tremelimumab actl 20 mg/mL Sol | $126,360 | $75,816 | — | — | 0 |
| 00406231 | ipilimumab 5 mg/mL IV Soln 40 mL | $110,582 | $66,349 | — | — | 0 |
| 00405290 | ravulizumab-cwvz 100 mg/mL intravenous solution 11 mL | $76,080 | $45,648 | — | — | 0 |
| 00405696 | inotuzumab ozogamicin 0.9 mg intravenous injection | $72,043 | $43,226 | — | — | 0 |
| 00440925 | mitoMYcin 80 mg Kit | $69,259 | $41,555 | — | — | 0 |
| 00405399 | polatuzumab vedotin-piiq 140 mg intravenous injection | $56,840 | $34,104 | — | — | 0 |
| 00405324 | tildrakizumab-asmn 100 mg/mL subcutaneous solution 1 mL | $53,190 | $31,914 | — | — | 0 |
| 00405274 | teprotumumab-trbw 500 mg intravenous injection | $51,582 | $30,949 | — | — | 0 |
| 00439117 | nivolumab-relatlimab rmbw 240 mg-80 mg/20 mL Sol | $47,086 | $28,252 | — | — | 0 |
| 00406272 | pegloticase 8 mg/mL IV Soln 1 mL | $45,360 | $27,216 | — | — | 0 |
| 00405605 | ustekinumab 45 mg/0.5 mL Subcut Soln 0.5 mL | $45,106 | $27,064 | — | — | 0 |
| 00406397 | cabazitaxel 60 mg/1.5 mL IV Soln 1.5 mL | $44,937 | $26,962 | — | — | 0 |
| 00433383 | dostarlimab gxly 500 mg/10 mL Sol | $36,730 | $22,038 | — | — | 0 |
| 00406025 | brentuximab vedotin 50 mg IV Inj | $36,619 | $21,971 | — | — | 0 |
| 00405944 | atezolizumab 60 mg/mL IV Soln 20 mL | $34,363 | $20,618 | — | — | 0 |
| 00433649 | ublituximab xiiy 150 mg/6 mL Sol | $33,931 | $20,359 | — | — | 0 |
| 00433516 | glofitamab gxbm 1 mg/mL Sol 10 mL | $33,110 | $19,866 | — | — | 0 |
| 00405597 | cemiplimab-rwlc 350 mg/7 mL intravenous solution 7 mL | $32,394 | $19,436 | — | — | 0 |
| 00404962 | risankizumab rzaa 60 mg/mL Sol 10 mL | $31,772 | $19,063 | — | — | 0 |
| 00405340 | daratumumab-hyaluronidase-fihj 1800 mg-30,000 units/15 mL subcutaneous solution 15 mL | $31,406 | $18,844 | — | — | 0 |
| 00406124 | vedolizumab 300 mg IV Inj | $28,080 | $16,848 | — | — | 0 |
| 00406249 | ipilimumab 5 mg/mL IV Soln 10 mL | $27,646 | $16,588 | — | — | 0 |
| 00418418 | tenecteplase 50 mg IV Inj | $26,884 | $16,130 | — | — | 0 |
| 00406173 | obinutuzumab 25 mg/mL IV Soln 40 mL | $26,705 | $16,023 | — | — | 0 |
| 00406199 | natalizumab 300 mg/15 mL | $26,599 | $15,959 | — | — | 0 |
| 00405472 | lurbinectedin 4 mg intravenous injection | $24,754 | $14,852 | — | — | 0 |
| 00405738 | nivolumab 10 mg/mL IV Soln 24 mL | $24,252 | $14,551 | — | — | 0 |
| 00413955 | agalsidase beta 35 mg IV Inj | $24,154 | $14,492 | — | — | 0 |
| 00405449 | atezolizumab 840 mg/14 mL intravenous solution 14 mL | $24,055 | $14,433 | — | — | 0 |
| 00425090 | antivenin (Micrurus fulvius) IV kit | $23,522 | $14,113 | — | — | 0 |
| 00421248 | hemin 313 mg IV Inj | $23,431 | $14,059 | — | — | 0 |
| 00418020 | carmustine 7.7 mg Implant Devive | $23,252 | $13,951 | — | — | 0 |
| 00406157 | ramucirumab 10 mg/mL IV Soln 50 mL | $23,138 | $13,883 | — | — | 0 |
| 00412882 | immune globulin 10% IV Soln 400 mL (Privigen) | $22,799 | $13,679 | — | — | 0 |
| 00406041 | panitumumab 20 mg/mL IV Soln 20 mL | $21,357 | $12,814 | — | — | 0 |
| 00406223 | pertuzumab 420 mg/14 mL IV Soln 14 mL | $21,147 | $12,688 | — | — | 0 |
| 00406462 | eculizumab 10 mg/mL IV Soln 30 mL | $21,135 | $12,681 | — | — | 0 |
| 00406132 | pegfilgrastim 6 mg/0.6 mL Sol (Onpro Kit) | $20,795 | $12,477 | — | — | 0 |
| 00406942 | pegfilgrastim 6 mg/0.6 mL Subcut Soln 0.6 mL (Syringe) | $20,795 | $12,477 | — | — | 0 |
| 00405563 | ravulizumab-cwvz 10 mg/mL intravenous solution 30 mL | $20,756 | $12,454 | — | — | 0 |
| 00433714 | ravulizumab-cwvz 100 mg/mL Sol 3mL | $20,749 | $12,449 | — | — | 0 |
| 00406405 | PRALAtrexate 20 mg/mL IV Soln 1 mL | $20,223 | $12,134 | — | — | 0 |
| 00405415 | ado-trastuzumab emtansine 160 mg IV Inj | $20,175 | $12,105 | — | — | 0 |
| 00404954 | efgartigimod alfa 400 mg/20 mL Sol | $19,664 | $11,798 | — | — | 0 |
| 00406439 | ixabepilone 45 mg intravenous injection | $18,822 | $11,293 | — | — | 0 |
| 00405639 | benralizumab 30 mg/mL subcutaneous solution 1 mL | $18,393 | $11,036 | — | — | 0 |
| 00406017 | pembrolizumab 25 mg/mL IV Soln 4 mL | $18,007 | $10,804 | — | — | 0 |
| 00405746 | siltuximab 400 mg intravenous injection | $17,192 | $10,315 | — | — | 0 |
| 00405662 | leuprolide 11.25 mg/3 months IM Inj, ER | $16,674 | $10,004 | — | — | 0 |
Showing top 50 of 4,762 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.